Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-23-008419
Filing Date
2023-11-14
Accepted
2023-11-14 15:01:48
Documents
104
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q avrw_10q.htm   iXBRL 10-Q 1245885
2 CERTIFICATION avrw_ex311.htm EX-31.1 10921
3 CERTIFICATION avrw_ex312.htm EX-31.2 11530
4 CERTIFICATION avrw_ex321.htm EX-32.1 5364
5 CERTIFICATION avrw_ex322.htm EX-32.2 5315
  Complete submission text file 0001477932-23-008419.txt   7082185

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA curr-20230930.xsd EX-101.SCH 94209
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE curr-20230930_lab.xml EX-101.LAB 424096
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE curr-20230930_cal.xml EX-101.CAL 67896
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE curr-20230930_pre.xml EX-101.PRE 355392
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE curr-20230930_def.xml EX-101.DEF 175655
98 EXTRACTED XBRL INSTANCE DOCUMENT avrw_10q_htm.xml XML 1279277
Mailing Address 5805 SEPULVEDA BLVD., SUITE 801 SHERMAN OAKS CA 91411
Business Address 5805 SEPULVEDA BLVD., SUITE 801 SHERMAN OAKS CA 91411 424-273-8675
Avenir Wellness Solutions, Inc. (Filer) CIK: 0001643301 (see all company filings)

EIN.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55908 | Film No.: 231404743
SIC: 2834 Pharmaceutical Preparations